Sign in

CIK 0001420565 · Non-accelerated filer<br>Smaller reporting company

Rein Therapeutics, Inc.

Sign in to watch
Ticker
RNTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
134196017
Phone
7378021989
Business address
12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TX, 78758
Former names
Aileron Therapeutics, Inc., AILERON THERAPEUTICS INC
  1. 8-K Event Regulation FD disclosure
  2. 8-K Event Delisting notice
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. 10-Q Report Quarterly Report
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. 8-K Event Shareholder vote results
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. ARS Other Annual Report to Security Holders
  10. DEFA14A Proxy Proxy Materials
  11. DEF 14A Proxy Proxy Statement
  12. 4 Insider Changes in Ownership
  13. PRE 14A Proxy Proxy Statement (Preliminary)
  14. 10-Q Report Quarterly Report
  15. 4 Insider Changes in Ownership
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G Stake Statement of Beneficial Ownership
  18. SCHEDULE 13G Stake Statement of Beneficial Ownership
  19. SCHEDULE 13G Stake Statement of Beneficial Ownership
  20. 8-K Event Material agreement · Other events

Page 1 of 27 · 525 filings